In addition, the ERCC2 gene could also increase the risk of hepatocellular carcinoma [24], acute lymphoblastic leukemia [25], lung cancer [26] and melanoma [27]. This evidence concerns the gene ERCC2 and acute lymphoblastic leukemia.